Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (615)	6/8/2007 9:10:55 PM
From: Mike McFarland	Respond to of 668

Well, that might be a little rich. Curis sure has gone through a lot of cash since inception. Still, I think Curis stock warrants a look and some nibbling here and there. I'll bet a shiny penny we see a buck sometime before the end of this year--and then $2 a year from now (or whatever it will be reverse split adjusted if they go that route). That is the way I am going to try and play it. The hedgehog program may pay modest dividends by next spring--a milestone if they get thru phase I and Genentech moves forward. And the unpartnered program could be interesting, although, you can't really tell anything from the presentation "Target A" unnamed could be smoke and mirrors for all I know.